Literature DB >> 19995557

Increase of RhoB in gamma-radiation-induced apoptosis is regulated by c-Jun N-terminal kinase in Jurkat T cells.

Chun-Ho Kim1, Misun Won, Chung-Hae Choi, Jiwon Ahn, Bo-Kyung Kim, Kyung-Bin Song, Chang-Mo Kang, Kyung-Sook Chung.   

Abstract

The Ras-related small GTP-binding protein RhoB is known to be a pro-apoptotic protein and immediate-early inducible by genotoxic stresses. In addition, JNK activation is known to function in gamma-radiation-induced apoptosis. However, it is unclear how JNK activation and gamma-radiation-dependent RhoB induction are related. Here we verified the relationship between JNK activation and RhoB induction. RhoB induction by gamma-radiation occurred at the transcriptional level and transcriptional activation of RhoB was concomitant with an increase in RhoB protein. gamma-Radiation-induced RhoB expression was markedly attenuated by pretreatment with a JNK-specific inhibitor, SP600125, but not by a p38 MAPK inhibitor, SB203580. Inhibition of JNK caused a decrease in early apoptotic cell death that correlated with RhoB expression. However, PI3K inhibition had no significant effects, indicating that the AKT survival pathway was not involved. The siRNA knockdown of JNK resulted in a decrease in RhoB expression and the siRNA knockdown of RhoB restored cell growth even in the gamma-irradiated cells. These results suggest that RhoB regulation involves the JNK pathway and contributes to the early apoptotic response of Jurkat T cells to gamma-radiation. Copyright 2009 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19995557     DOI: 10.1016/j.bbrc.2009.12.012

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

1.  NSC126188, a piperazine alkyl derivative, induces apoptosis via upregulation of RhoB in HeLa cells.

Authors:  Bo-Kyung Kim; Dong-Myung Kim; Kyung-Sook Chung; Song-Kyu Park; Shin-Jung Choi; Alexander Song; Kiho Lee; Chang-Woo Lee; Kyung-Bin Song; Gyoonhee Han; Julian Simon; Hwan Mook Kim; Misun Won
Journal:  Invest New Drugs       Date:  2010-04-30       Impact factor: 3.850

2.  Protocatechuic acid inhibits cancer cell metastasis involving the down-regulation of Ras/Akt/NF-κB pathway and MMP-2 production by targeting RhoB activation.

Authors:  Hui-Hsuan Lin; Jing-Hsien Chen; Fen-Pi Chou; Chau-Jong Wang
Journal:  Br J Pharmacol       Date:  2011-01       Impact factor: 8.739

3.  RhoB promotes γH2AX dephosphorylation and DNA double-strand break repair.

Authors:  Kenza Mamouni; Agnese Cristini; Josée Guirouilh-Barbat; Sylvie Monferran; Anthony Lemarié; Jean-Charles Faye; Bernard S Lopez; Gilles Favre; Olivier Sordet
Journal:  Mol Cell Biol       Date:  2014-06-09       Impact factor: 4.272

4.  Inhibition of c-Jun N-terminal kinase activity enhances vestibular schwannoma cell sensitivity to gamma irradiation.

Authors:  Wei Ying Yue; J Jason Clark; Michael Telisak; Marlan R Hansen
Journal:  Neurosurgery       Date:  2013-09       Impact factor: 4.654

Review 5.  Rho GTPases in cancer radiotherapy and metastasis.

Authors:  Rui-Jie Zeng; Chun-Wen Zheng; Wan-Xian Chen; Li-Yan Xu; En-Min Li
Journal:  Cancer Metastasis Rev       Date:  2020-08-08       Impact factor: 9.264

6.  Prolonged application of high fluid shear to chondrocytes recapitulates gene expression profiles associated with osteoarthritis.

Authors:  Fei Zhu; Pu Wang; Norman H Lee; Mary B Goldring; Konstantinos Konstantopoulos
Journal:  PLoS One       Date:  2010-12-29       Impact factor: 3.240

7.  The nuclear guanine nucleotide exchange factors Ect2 and Net1 regulate RhoB-mediated cell death after DNA damage.

Authors:  Melissa C Srougi; Keith Burridge
Journal:  PLoS One       Date:  2011-02-23       Impact factor: 3.240

8.  Suppression of FOXM1 sensitizes human cancer cells to cell death induced by DNA-damage.

Authors:  Marianna Halasi; Andrei L Gartel
Journal:  PLoS One       Date:  2012-02-29       Impact factor: 3.240

9.  The c-Jun/RHOB/AKT pathway confers resistance of BRAF-mutant melanoma cells to MAPK inhibitors.

Authors:  Audrey Delmas; Julia Cherier; Magdalena Pohorecka; Claire Medale-Giamarchi; Nicolas Meyer; Anne Casanova; Olivier Sordet; Laurence Lamant; Ariel Savina; Anne Pradines; Gilles Favre
Journal:  Oncotarget       Date:  2015-06-20
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.